sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 801-825 out of 1314.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>

Public Release: 27-Jul-2015
Journal of Experimental Medicine
Malaria's key to the liver uncovered
Scientists uncover a port of liver entry for malaria parasites, and if these results hold up in humans, drugs that target this entry protein might help prevent the spread of disease.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Rita Sullivan King
Rockefeller University Press

Public Release: 27-Jul-2015
PLOS Biology
Some vaccines support evolution of more-virulent viruses
Scientific experiments with the herpesvirus such as the one that causes Marek's disease in poultry have confirmed, for the first time, the highly controversial theory that some vaccines could allow more-virulent versions of a virus to survive, putting unvaccinated individuals at greater risk of severe illness. The research has important implications for food-chain security and food-chain economics, as well as for other diseases that affect humans and agricultural animals.
NIH/National Institutes of Health Institute of General Medical Sciences, Biotechnology and Biological Sciences Research Council, NSF-NIH-USDA/Ecology and Evolution of Infectious Diseases Program

Contact: Barbara K. Kennedy
Penn State

Public Release: 26-Jul-2015
American Society of Tropical Medicine and Hygiene
Diabetes-TB link found in Australia
A 20-year study by James Cook University scientists has found a strong link between diabetes and tuberculosis in tropical Australia.

Contact: Alistair Bone
James Cook University

Public Release: 23-Jul-2015
Journal of Women's Health
Can patient navigators reduce no-shows for cancer screening follow-up?
Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20 percent decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient navigator program was initiated at the referral center. The impact of the program and the main reasons for patient no-shows are explored in an article in Journal of Women's Health.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 23-Jul-2015
Genome Research
Fighting mosquito resistance to insecticides
Controlling mosquitoes that carry human diseases is a global health challenge as their ability to resist insecticides now threatens efforts to prevent epidemics. Scientists from the CNRS, IRD, Université Claude Bernard Lyon 1, Université Joseph Fourier in Grenoble and Institut Pasteur in French Guiana have identified new genetic markers for mosquito resistance to insecticides, which could improve its detection in the field. This work was published in Genome Research on July 23, 2015.
Centre National de la Recherche Scientifique, French Institut de Microbiologie et MaladiesInfectieuses, Laboratoire d'Ecologie Alpine of Grenoble

Contact: Peggy Calicchia
Cold Spring Harbor Laboratory

Public Release: 22-Jul-2015
Journal of Immunology
New smart drug targets and reduces site-specific inflammation
The uniqueness of this novel anti-inflammatory molecule, reported in the current issue of Journal of Immunology, can be found in a singular property. When injected, it is as a non-active drug. However, a localized site with excessive inflammation will activate it. Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis.
Kamin program of Israel's Ministry of Economy's Chief Scientist's Office

Contact: Andrew Lavin
American Associates, Ben-Gurion University of the Negev

Public Release: 22-Jul-2015
University of Southampton to map impact of infectious diseases against research spending
Scientists at the University of Southampton are set to analyze research investments into infectious disease research, particularly pneumonia and maternal and neonatal infections, after receiving over £370,000 in funding from the Bill & Melinda Gates Foundation.
Bill & Melinda Gates Foundation

Contact: Steven Williams
University of Southampton

Public Release: 22-Jul-2015
New England Journal of Medicine
Antiviral compound protects nonhuman primates against Marburg virus
An experimental drug that protected monkeys from the deadly Marburg virus appears to have potential for treating people who have been exposed to the virus, according to a study published in the July 23 edition of The New England Journal of Medicine. Marburg virus is closely related to Ebola virus and also causes a severe hemorrhagic fever.
Joint Product Management Office of BioDefense Therapeutics-Medical Countermeasure Systems Joint Project Management Office-US Department of Defense, Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 22-Jul-2015
International Journal of Epidemiology
Educational benefits of deworming children questioned by re-analysis of flagship study
Deworming children may not improve school attendance and the evidence that informs international policy needs to be re-appraised following a major re-analysis of data from an influential trial.
International Initiative for Impact Evaluation

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 21-Jul-2015
Diabetes Care
Poor diabetes control found in older Americans
Only one in three older Americans have their diabetes under control as measured by guidelines set by the American Diabetes Association, new Johns Hopkins Bloomberg School of Public Health research suggests.

Contact: Barbara Benham
Johns Hopkins University Bloomberg School of Public Health

Public Release: 20-Jul-2015
Journal of Experimental Medicine
Stopping malaria in its tracks
A new drug acts as a roadblock for malaria, curing mice of established infection, according to researchers. Treatment was not associated with obvious side effects, suggesting that the drug may also be safe and effective in humans.
Wellcome Trust, National Research Foundation Singapore

Contact: Rita Sullivan King
Rockefeller University Press

Public Release: 17-Jul-2015
100th Annual Meeting of the Ecological Society of America
Infectious disease ecology, forest biodiversity, urban ecology featured at upcoming conference
The ecology of cities across the US, spread of infectious diseases such as Ebola, worldwide forests under siege, and how life thrives in Earth's critical zone are among the topics featured at the 2015 meeting of the Ecological Society of America, held Aug. 9-14, 2015 in Baltimore, Md.

Contact: Cheryl Dybas
National Science Foundation

Public Release: 17-Jul-2015
Science Translational Medicine
New malaria treatment thwarts parasite resistance
As increasing resistance in parasites undermines the effectiveness of current drugs, two new compounds are raising hopes in the ongoing battle against malaria

Contact: Michael Jacobson
Griffith University

Public Release: 17-Jul-2015
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
Cholesterol metabolism in immune cells linked to HIV progression, may lead to new therapy
Enhanced cholesterol metabolism in certain immune cells may help some people infected with HIV naturally control disease progression, according to new research from the University of Pittsburgh Graduate School of Public Health.
National Institutes of Health

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 16-Jul-2015
PLOS Neglected Tropical Diseases
Burden of dengue, chikungunya in India far worse than understood
New Johns Hopkins Bloomberg School of Public Health research finds new evidence that an extremely high number of people in southern India are exposed to two mosquito-borne viruses -- dengue and chikungunya.
Burroughs Wellcome Fund

Contact: Stephanie Desmon
Johns Hopkins University Bloomberg School of Public Health

Public Release: 16-Jul-2015
Current Biology
University of Washington researchers show that the mosquito smells, before it sees, a host
A team of biologists from the University of Washington and the California Institute of Technology has cracked the cues mosquitoes use to find human hosts.
National Institutes of Health

Contact: James Urton
University of Washington

Public Release: 16-Jul-2015
PLOS Pathogens
Repeat infection with malaria parasites might make mosquitoes more dangerous
In malaria-endemic regions, humans are often infected repeatedly with the Plasmodium parasite. Little is known about possible co-infection and its consequences in the Anopheles mosquitoes that transmit the disease. A study published on July 16 in PLOS Pathogens reports that not only can individual mosquitoes accumulate infections from multiple blood feeds, but also that an existing malaria infection makes mosquitoes more susceptible to a second infection, and that infections reach higher densities when another strain is already present.

Contact: Laura Pollitt

Public Release: 16-Jul-2015
PLOS Pathogens
Breakthrough finding brings cure for flesh-eating skin disease 1 step closer
Scientists from the University of Surrey have made an important breakthrough in the fight against the flesh-eating tropical skin disease Buruli ulcer, by their discovery that the bacteria causes a blood clot in patients' skin, similar to those that cause deep vein thrombosis (DVT). The new findings mean that, like DVT, the clots may respond to anticoagulant medicines, heal more quickly and with fewer side effects than with antibiotics alone.

Contact: Peter La
University of Surrey

Public Release: 15-Jul-2015
Science Translational Medicine
Researchers have shown that a drug currently in testing shows potential to cure malaria
Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.

Contact: Debbie Bolles
UT Southwestern Medical Center

Public Release: 15-Jul-2015
UGA researchers develop breakthrough tools in fight against cryptosporidium
Researchers at the University of Georgia have developed new tools to study and genetically manipulate cryptosporidium, a microscopic parasite that causes the diarrheal disease cryptosporidiosis. Their discoveries, published in the journal Nature, will ultimately help researchers in academia and industry find new treatments and vaccines for cryptosporidium, which is a major cause of disease and death in children under two years old.
National Institutes of Health, US Centers for Disease Control and Prevention, UGA Research Foundation, Georgia Research Alliance

Contact: Boris Striepen
University of Georgia

Public Release: 15-Jul-2015
Molecular Psychiatry
High blood levels of growth factor correlate with smaller brain areas in patients with schizophrenia
High blood levels of a growth factor known to enable new blood vessel development and brain cell protection correlate with a smaller size of brain areas key to complex thought, emotion and behavior in patients with schizophrenia, researchers report in the journal Molecular Psychiatry.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 15-Jul-2015
Science Translational Medicine
University of Washington chemists help develop a novel drug to fight malaria
An international team of scientists -- led by researchers from the University of Washington and two other institutions -- has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive, and is suitable for clinical tests in humans.
National Institutes of Health

Contact: James Urton
University of Washington

Public Release: 14-Jul-2015
The Global Response to Ebola: Implications for Future Drug & Vaccine Development
Ebola vaccine trial begins in Senegal
A trial evaluating an Ebola vaccine has begun in Dakar, after initial work at Oxford's Jenner Institute. The announcement comes as a conference in Oxford discusses the global response to Ebola and implications for future drug and vaccine development. The first volunteers at Centre Hospitalier Universitaire le Dantec, Dakar, received an initial vaccination with a booster one week later. This short timescale could provide an option for a rapid vaccination programme in an outbreak.
European Union Horizon 2020 research and innovation programme, Wellcome Trust, UK Department of International Development

Contact: University of Oxford news office
University of Oxford

Public Release: 14-Jul-2015
More women, children now on lifesaving HIV treatment worldwide
Global scale-up of prevention of mother-to-child transmission of HIV services has yielded remarkable results. Between 2000 and 2014, the percentage of pregnant women living with HIV with access to ART rose to 73 percent and new HIV infections among children dropped by 58 percent--leading to 1.4 million averted pediatric HIV infections worldwide.

Contact: Johanna Harvey
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 13-Jul-2015
Journal of Bone and Mineral Research
Kidney, bladder stones do not increase postmenopausal women's risk of osteoporosis
Postmenopausal women with kidney or bladder stones are not at increased risk for osteoporosis, but they do have about a 15 percent increased risk of another painful stone, physician-scientists report.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Showing releases 801-825 out of 1314.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>